Review



primary human umbilical artery smcs (huasmcs)  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Lonza primary human umbilical artery smcs (huasmcs)
    Primary Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pm26987444-27-0-7?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    human umbilical artery smooth muscle cells smcs  (PromoCell)
    94
    PromoCell human umbilical artery smooth muscle cells smcs
    Human Umbilical Artery Smooth Muscle Cells Smcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pm40778606-504-132-141?v=PromoCell
    Average 94 stars, based on 1 article reviews
    human umbilical artery smooth muscle cells smcs - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    human umbilical artery smcs huasmcs  (Procell Inc)
    86
    Procell Inc human umbilical artery smcs huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs Huasmcs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pmc12433515-134-5-15?v=Procell+Inc
    Average 86 stars, based on 1 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    primary human umbilical artery smcs (huasmcs)  (Lonza)
    90
    Lonza primary human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Primary Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pm26987444-27-0-7?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs)  (ScienCell)
    90
    ScienCell human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pm27959397-30-0-8?v=ScienCell
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579)  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs) (Clonetics, Lonza, Cat. No. Cc 2579), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pmc04059065-64-28-34?v=Lonza
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs)  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pmc04059065-169-27-33?v=Lonza
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pmc04059065-197-25-31?v=Lonza
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs huasmcs  (PromoCell)
    94
    PromoCell human umbilical artery smcs huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs Huasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+%28huasmcs%29/pm14597670-34-25-33?v=PromoCell
    Average 94 stars, based on 1 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of bare and coating-modified groups on SMCs proliferation. (A–C) Representative fluorescence images of HUASMCs cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Bioactive Materials

    Article Title: A hierarchical MgF 2 /polyurethane/pitavastatin coating alleviates degradation and enhances endothelialization of bioresorbable magnesium alloy stents

    doi: 10.1016/j.bioactmat.2025.08.038

    Figure Lengend Snippet: Effects of bare and coating-modified groups on SMCs proliferation. (A–C) Representative fluorescence images of HUASMCs cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: Human umbilical vein ECs (HUVECs), human umbilical artery SMCs (HUASMCs), and MΦs were obtained from Procell Life Science & Technology Co., Ltd. All cell lines were maintained and passaged in a cell culture incubator at 37 °C with 5 % CO 2 .

    Techniques: Modification, Fluorescence, Control, Expressing, Comparison